BTC004: Bitcoin Tech & Future Growth w/ Blockstream’s Samson Mow

Videos
On today’s Bitcoin Fundamentals Show, Preston talks with Blockstream’s Samson Mow about the future growth of Bitcoin. Samson is the Chief Strategy Officer and he talks about incorporating Bitcoin into many different layers which will leverage utility tokens and security tokens above the Bitcoin layer.

IN THIS EPISODE, YOU’LL LEARN:
-The early days of Blockstream
-The fork wars and why they were important to future growth
-What is transaction value per second and why’s it important
-Where he sees Bitcoin in the next five years
-The Lightning Network
-Liquid
-Green and Aqua
-Security & utility tokens on top of Bitcoin
-Blockstream satellites
-Gaming and Bitcoin

Subscribe to We Study Billionaires podcast show: https://link.chtbl.com/WSB

To access our show notes, courses or forums, go to theinvestorspodcast.com.
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
ADDITIONAL INVESTING RESOURCES:
Ask the Investors: https://www.youtube.com/playlist?list…

Asset Allocation Course: https://www.youtube.com/playlist?list…

Real Estate Investing: https://www.youtube.com/playlist?list…

Millennial Investing: https://www.youtube.com/playlist?list…
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
Download Stig & Preston’s 1-page checklist for finding great stock picks: https://www.theinvestorspodcast.com/f…

Have a question? Get your voice heard on the show: https://www.theinvestorspodcast.com/y…
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
DISCLAIMER: This show is for entertainment purposes only. Before making any decisions consult a professional. This show is copyrighted by The Investor’s Podcast Network. Written permission must be granted before syndication or rebroadcasting.

Articles You May Like

Top Wall Street analysts like these dividend-paying stocks
Trump is the most pro-stock market president in history, Wharton’s Jeremy Siegel says
AI’s Dark Horse Could Become Its Crown Jewel Under Trump
Gary Gensler reviews his accomplishments, says he was ‘proud to serve’ as SEC chair
Caligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value